Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas R. Teman, MD"'
Autor:
Andrew M. Young, MD, Raymond J. Strobel, MD, MSc, Emily Kaplan, BA, Anthony V. Norman, MD, Raza Ahmad, MD, John Kern, MD, Leora Yarboro, MD, Kenan Yount, MD, Matthew Hulse, MD, Nicholas R. Teman, MD
Publikováno v:
JTCVS Open, Vol 16, Iss , Pp 464-476 (2023)
Objective: Postoperative delirium after cardiac surgery is associated with long-term cognitive decline and mortality. We investigated whether increased ICU Confusion Assessment Method scores were associated with greater 30-day mortality and failure t
Externí odkaz:
https://doaj.org/article/512bcd98810447b99a513e53406ec07a
Autor:
Robert B. Hawkins, MD, MSc, Erik Scott, MD, MS, J. Hunter Mehaffey, MD, MSc, Raymond J. Strobel, MD, MSc, Alan Speir, MD, Mohammed Quader, MD, Nicholas R. Teman, MD, Leora T. Yarboro, MD
Publikováno v:
JTCVS Open, Vol 13, Iss , Pp 218-231 (2023)
Objectives: The 2018 change in the heart transplant allocation system resulted in greater use of temporary mechanical circulatory support. We hypothesized that the allocation change has increased hospital resource utilization, including length of sta
Externí odkaz:
https://doaj.org/article/421ce8dc304b413c8458ae4de7e50022
Autor:
J. Hunter Mehaffey, MD, MSc, Ryan Cantor, PhD, Susan Myers, MS, Nicholas R. Teman, MD, John A. Kern, MD, Gorav Ailawadi, MD, Francis Pagani, MD, James Kirklin, MD, Kenan Yount, MD, MBA, Leora Yarboro, MD
Publikováno v:
JTCVS Open, Vol 9, Iss , Pp 122-143 (2022)
Objective: Chronic kidney disease and renal failure are common in patients being considered for left ventricular assist device support. We sought to evaluate the outcomes of patients undergoing left ventricular assist device implantation with preoper
Externí odkaz:
https://doaj.org/article/f1ee3e006d5f4f5abcff2e7b66b54149
Autor:
Belinda Rivera-Lebron MD, MS, FCCP, Michael McDaniel MD, FACC, FSCAI, Kamran Ahrar MD, MBA, Abdulah Alrifai MD, David M. Dudzinski MD, Christina Fanola MD, MSC, Danielle Blais PharmD, BCPS-AQ Cardiology, David Janicke MD, PhD, Roman Melamed MD, FCCP, Kerry Mohrien PharmD, BCPS, Elizabeth Rozycki PharmD, BCPS, Charles B. Ross MD, FACS, Andrew J. Klein MD, Parth Rali MD, Nicholas R. Teman MD, Leoara Yarboro MD, Eugene Ichinose MD, Aditya M. Sharma MBBS, Jason A. Bartos MD, PhD, Mahir Elder MD, FACC, FSCAI, FCCP, Brent Keeling MD, Harold Palevsky MD, Soophia Naydenov MD, FCCP, Parijat Sen MBBS, MD, Nancy Amoroso MD, Josanna M. Rodriguez-Lopez MD, George A. Davis Pharm D, Rachel Rosovsky MD, Kenneth Rosenfield MD, MHCDS, FACC, FSCAI, Christopher Kabrhel MD, MPH, James Horowitz MD, Jay S. Giri MD, MPH, Victor Tapson MD, FCCP, FRCP, Richard Channick MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity and mortality. There have been many advances in the field of PE in the last few years, requiring a careful assessment of their impact on patient care. However, v
Externí odkaz:
https://doaj.org/article/f878eb54aa9b4bd79415ba74637761d2